Similar articles

• [Population screening for colon and rectum cancer using the Hemoccult test].

  van Tongeren JH. van Tongeren JH. Ned Tijdschr Geneeskd. 1982 Oct 23;126(43):1967-9. Ned Tijdschr Geneeskd. 1982. PMID: 7177204 Dutch. No abstract available.
• Hemoccult screening for colorectal cancer in Missouri.

  Linne JH, Fulbeck CT, Butt JH, Huston JD, Butt MT, Jaco D. Linne JH, et al. Mo Med. 1983 Jun;80(6):309-12. Mo Med. 1983. PMID: 6877226 No abstract available.
• Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood.

  Shields HM, Weiner MS, Henry DR, Lloyd JA, Ransil BJ, Lamphier DA, Gallagher DW, Antonioli DA, Rosner BA. Shields HM, et al. Am J Gastroenterol. 2001 Jan;96(1):196-203. doi: 10.1111/j.1572-0241.2001.03475.x. Am J Gastroenterol. 2001. PMID: 11197252
• Clinical Inquiries. How does colonoscopy compare with fecal occult blood testing as a screening tool for colon cancer?

  Boggs BD, Stephens MM, Wallace R. Boggs BD, et al. J Fam Pract. 2005 Nov;54(11):996-7. J Fam Pract. 2005. PMID: 16266608 Review. No abstract available.
• Reducing the incidence and mortality of colon cancer: mass screening and colonoscopic polypectomy.

  Cappell MS. Cappell MS. Gastroenterol Clin North Am. 2008 Mar;37(1):129-60, vii-viii. doi: 10.1016/j.gtc.2007.12.003. Gastroenterol Clin North Am. 2008. PMID: 18313544 Review.